Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04723537
Brief Title: Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease

First Submitted : January 18, 2021
First Submitted that Met QC Criteria : January 21, 2021
First Posted : January 25, 2021

Last Update Submitted that Met QC Criteria : April 13, 2021
Last Update Posted : April 15, 2021